Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

942.55

3.35 (0.36%)

< Home < Back

Zydus Lifesciences Ltd. News

>>

Zydus receives final approval for Clonidine Hcl Injection

>>

Cadila Healthcare trades higher on the BSE

>>

Cadila Healthcare jumps on reporting 82% surge in Q3 consolidated net profit

>>

Cadila Healthcare reports 82% surge in Q3 consolidated net profit

>>

Zydus receives final approval for Etodolac ER Tablets

>>

Cadila Healthcare trades higher on the BSE

>>

Cadila Healthcare strengthens on the bourses

>>

Cadila Healthcare to exit from its business in Japan

>>

Cadila Healthcare spurts on receiving final approval for Bupropion Hcl ER Tablets

>>

Zydus receives final approval for Bupropion Hcl ER Tablets

<< < 159 160 161 ...168 > >>